Pharma
Overview
TRACEABILITY
The absence of traceability at the unit level during industrial production can lead to several issues, including product mix-ups and quality issues. Today, if a problem is identified during a manufacturing step, it is not possible to define exactly which products may have been impacted. This lack of information results in the adoption of over-segregation and full batch write-off policies, where entire batches of products are eliminated. Consequently, even products suitable for commercialization may be discarded due to the inability to distinguish them clearly from affected products and this can have a significant financial impact. Unit-level traceability is essential: each container can be tracked at every stage of the production process, from forming to filling and automated inspection, right through to the point of care. Unique identification can provide insight into each process, and this data can be used to perform a more detailed root cause analysis, reject cause tracking, corrective actions and adjustments to product design and process optimization. It is possible to obtain a more secure and automated line reconciliation system.
Anticounterfeit
In the pharmaceutical sector, the counterfeit products infiltrate the market, particularly affecting developing nations where estimates suggest up to 30% of products may be counterfeit. This global issue is underscored by estimations placing the value of counterfeit pharmaceuticals between 200 and 430 billion USD dollars. The ramifications extend far beyond financial losses and damage to the brand reputation, with profound economic and social consequences: although it is difficult to objectively quantify precise figures, the World Health Organization (WHO) estimates that there are more than 100,000 deaths each year just considering counterfeit malaria drugs. Unit-level identification can seriously hinder product diversion and grey markets, raising new barriers against counterfeiting and tampering. Unique ID codes can also be made completely invisible to the human eye, acting as a covert anti-counterfeiting feature.
OUR PROPOSAL
It is therefore necessary to have marking solutions capable of producing unique markings on individual products, while respecting industrial volumes and speeds. SAMS solutions can meet these requirements, even for highly demanding supply chains such as the pharmaceutical industry. We can create a unique ID on each and every primary packaging product just after its production or along a pharma industrial line, so that the individual container, and thus the individual product, can be tracked from the beginning of the supply chain up to its disposal. We can enable not only traceability in the classical sense, i.e., with a unique alphanumeric code for each object, but it is possible to include within the code the information needed to link the physical object to a digital copy of the product. This link will provide easy access to a wealth of data for all users in the supply chain and serve as an element of security and quality assurance.
Discover our solutions best suited to your needs!
